Literature DB >> 11372741

Prolonged bone marrow failure with monosomy 7 after engraftment failure following bone marrow transplantation.

R Kobayashi1, H Arioka, M Yoshida, Y Cho, A Iguchi, M Kaneda, T Shikano.   

Abstract

A patient with acute myelogenous leukemia developed prolonged bone marrow failure along with the monosomy 7 chromosome abnormality. The patient had undergone bone marrow transplantation with CD34+ selection following induction failure. However, she then suffered engraftment failure and long-term pancytopenia. Her white blood cell count gradually increased with supportive therapy including granulocyte colony-stimulating factor (G-CSF), and chromosomal analysis of bone marrow cells revealed an abnormal karyotype. Thirty months after the bone marrow transplantation we observed monosomy 7 together with the existing chromosomal abnormality in the patient's bone marrow cells. It has been reported that some patients with idiopathic and posthepatitis aplastic anemia develop clonal disorders such as myelodysplastic syndrome/acute myelogenous leukemia with monosomy 7. The findings in our case suggest that the appearance of monosomy 7 in patients with aplastic anemia may be caused by prolonged low-level hematopoiesis, with or without G-CSF stimulation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11372741     DOI: 10.1007/bf02981947

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  20 in total

1.  Increased risk of second cancers in managing Hodgkins disease: the 20-year Leiden experience.

Authors:  J K Sont; W A van Stiphout; E M Noordijk; J Molenaar; J H Zwetsloot-Schonk; R Willemze; J P Vandenbroucke
Journal:  Ann Hematol       Date:  1992-11       Impact factor: 3.673

Review 2.  Cytogenetic findings in primary and secondary MDS.

Authors:  S Heim
Journal:  Leuk Res       Date:  1992       Impact factor: 3.156

Review 3.  Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation.

Authors:  J Pedersen-Bjergaard; M K Andersen; D H Christiansen
Journal:  Blood       Date:  2000-06-01       Impact factor: 22.113

4.  Late haematological complications in severe aplastic anaemia.

Authors:  A Tichelli; A Gratwohl; A Würsch; C Nissen; B Speck
Journal:  Br J Haematol       Date:  1988-07       Impact factor: 6.998

5.  Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group.

Authors:  N Frickhofen; J P Kaltwasser; H Schrezenmeier; A Raghavachar; H G Vogt; F Herrmann; M Freund; P Meusers; A Salama; H Heimpel
Journal:  N Engl J Med       Date:  1991-05-09       Impact factor: 91.245

6.  Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia.

Authors:  A Ohara; S Kojima; N Hamajima; M Tsuchida; S Imashuku; S Ohta; H Sasaki; J Okamura; K Sugita; H Kigasawa; Y Kiriyama; J Akatsuka; I Tsukimoto
Journal:  Blood       Date:  1997-08-01       Impact factor: 22.113

7.  Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia.

Authors:  S J Rosenfeld; J Kimball; D Vining; N S Young
Journal:  Blood       Date:  1995-06-01       Impact factor: 22.113

8.  Evolution of severe aplastic anemia to myelodysplasia with monosomy 7 following granulocyte colony-stimulating factor, erythropoietin and high-dose methylprednisolone combination therapy.

Authors:  A Ohsaka; Y Sugahara; Y Imai; M Kikuchi
Journal:  Intern Med       Date:  1995-09       Impact factor: 1.271

9.  Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies.

Authors:  D L Darrington; J M Vose; J R Anderson; P J Bierman; M R Bishop; W C Chan; M E Morris; E C Reed; W G Sanger; S R Tarantolo
Journal:  J Clin Oncol       Date:  1994-12       Impact factor: 44.544

10.  Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party.

Authors:  A Bacigalupo; G Broccia; G Corda; W Arcese; M Carotenuto; A Gallamini; F Locatelli; P G Mori; P Saracco; G Todeschini
Journal:  Blood       Date:  1995-03-01       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.